![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
ORIGINAL ARTICLE
Esperienze Dermatologiche 2021 June;23(2):29-32
DOI: 10.23736/S1128-9155.21.00520-3
Copyright © 2021 EDIZIONI MINERVA MEDICA
language: English, Italian
A cosmetic preparation for the prevention of pigmentation after laser treatment of solar lentigines
Diletta BONCIANI 1 ✉, Giovanni CANNAROZZO 2
1 Unit of Dermatology, San Jacopo Hospital, Pistoia, Italy; 2 Unit of Dermatology, Tor Vergata University, Rome, Italy
BACKGROUND: Post-inflammatory hyperpigmentation (PIH) after solar lentigo removal using a Q-switched (QS) 532-nm Nd:YAG laser is a cause for concern. This study aimed to evaluate the efficacy and safety of a new depigmenting cosmetic for the prevention of PIH after QS 532-nm Nd:YAG laser treatment of solar lentigines.
METHODS: In total, 20 patients with solar lentigines on the face underwent QS 532-nm Nd:YAG laser treatment. Then, the cosmetic treatment was applied from the day 5 after the treatment for 3 weeks, in 10 patients and only sunscreen was applied in the other 10 patients; treatments were randomly assigned. Two blinded dermatologists evaluated photographs at baseline, and at week 4.
RESULTS: The tolerability of the cosmetic treatment was excellent or good in all patients; the tolerability of the sunscreen was excellent or good in 80% of patients and moderate in 20%. PIH was observed only in one (10%) patient after the cosmetic treatment, but it was present in six (60%) of those receiving the sunscreen (P=0.022 vs. cosmetic treatment). The relative risk of developing PIH in patients treated with the cosmetic treatment versus sunscreen was 0.17 (95% CI: 0.02-1.14, P=0.068).
CONCLUSIONS: The use of this cosmetic treatment after 532-nm QS Nd:YAG laser treatment of solar lentigines can reduce the risk of developing PIH after 4 weeks.
KEY WORDS: Hyperpigmentation; Laser therapy; Lentigo; Prevention and control; Skin lightening preparations